Skip to main content
SpringerLink
Log in

AMACING: no prophylaxis safe and cost saving versus hydration

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2015 euros

Reference

  • Nijssen EC, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet : 20 Feb 2017. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(17)30057-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

AMACING: no prophylaxis safe and cost saving versus hydration. Reactions Weekly 1641, 5 (2017). https://doi.org/10.1007/s40278-017-26919-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-26919-5

Search

Navigation